Jeffrey L. Bennett, MD, PhD - University of Colorado Denver
Jeffrey L. Bennett, MD, PhD - University of Colorado Denver
Jeffrey L. Bennett, MD, PhD - University of Colorado Denver
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
NMO: To Treat or Not To Treat<br />
AQP4-IgG Seropositivity<br />
50% chance <strong>of</strong> relapse in 1 year<br />
Visual Prognosis<br />
•70% severe vision loss in one eye (8 yrs)<br />
–MS Cohort: 8.5%<br />
•Average time to severe vision loss<br />
–Monocular: 2 ± 0.8 years<br />
–Binocular: 13 ± 3 years<br />
Ambulatory Prognosis<br />
• Median time to EDSS 4: 7 years<br />
• Median time to EDSS 6: 10 years Collongues, et al. (2010).<br />
Neurology, 74:736.
Change language